Shock and Its
Management
prep by shah Fahad Khalid
BS Cardiology KMU/IPMS(GM)
Lecturer at Abasyn university
Introduction to shock
Possible causes of shock
Pre-shock symptoms
Sign and symptoms
Assessment of Shock Patient
Generalized Treatment
Types of shock
Management of each shock type
accordingly
Monitoring and care to the shock
patient
Topic
Outlines
 Acute circulatory failure.
 Decreased organs perfusion.
 Inadequate oxygen delivery.
 End organ dysfunction.
 Actually it is the imbalance between demand and supply of oxygen.
 Inability to utilize oxygen
 A temporary stage of unconsciousness.
Shock
 Failure of oxygen delivery system
◦ Hypoxia
◦ Oxygen deficient environment
i.e. high altitude.
 Injury to the lungs/ Lung disease/
unable to transform oxygen into
the blood.
◦ Pneumonia
◦ CHF
◦ Traumatized lungs
◦ Pulmonary embolism
◦ Pulmonary edema
◦ Hemo/hydro/pneumothorax
◦ Respiratory arrest
 Burns
 Diarrhea/vomiting (persistent)
 Spinal injuries (neurogenic)
 Heart related problems
◦ CHF
◦ MI
◦ Heart attack/cardiac arrest
◦ Arrhythmias
◦ Pericarditis/endocarditis
◦ Pericardial effusion
◦ CAD
 RBCs related
◦ Anemia
◦ Bleeding disorders
◦ Hemolysis
 Body fluids (dehydration)
 Hypotension due to
vasodilation or any other
causes.
Possible
Causes of
Shock
 Rapid but shallow breathing
 Feeling to get fainted
 Dizziness starts
 Blacking out of eye
 Nausea
 Feeling of General weakness
 Facial flushing
Pre-shock
Symptoms
 Low Bp
 Tachycardia
(compensatory)
 Rapid but shallow
breathing persists
 Cold and clammy skin
 Rapid but weak pulse
 Dizziness/fainting
 General weakness
 Type dependent sign
and symptoms
◦ Anxiety or agitation
◦ Seizures
◦ Confusion/
unresponsiveness
◦ Low or no urine
output
◦ Peripheral cyanosis
◦ Sweating
◦ Chest pain.
Sign and
Symptoms
 ABC Protocol
◦ Airway
◦ Breathing
◦ Circulation
 ABCDE Protocols
◦ Airway
◦ Breathing
◦ Circulation
◦ Disability
◦ Exposure
 BLUE protocol: Bed Side Lung Ultrasonography in
Emergency.
 FALLS Protocol: Fluid Administration Limited by Lungs
Sonography.
 GCS scaling(15)
Assessment
Protocols
https://www.resus.org.uk/resu
scitation-guidelines/abcde-ap
proach/
 Main types
◦ Obstructive Shock
◦ Cardiogenic Shock
◦ Distributive Shock
◦ Hypovolemic Shock
Types of Shock
 Actual physical cause
 Underlying pathology
 Optimization of
◦ Cardiac output
◦ Blood pressure
◦ Oxygen delivery
 Vascular tone restoration
 Prevent any end organ failure
 Or at least give supportive therapy
(pharmacological/prophylactic).
Generalized
Treatment
 Obstruction of blood flow
into / out of the heart.
 Impaired diastolic filling and
decreased cardiac output.
 Causes:
◦ Pulmonary
◦ Circulatory occlusion
◦ Heart itself
 Acute pericardial
tamponade,
 Pulmonary or systemic
hypertension
 Massive pulmonary emboli
occluding >50% of vascular
bed.
Obstructiv
e Shock
 CO is decreased
 CVP is elevated,
 SVR is increased, and
 Echocardiography is the definitive
diagnostic tool for Obstructive shock.
Diagnostic
Variables
Parameter Normal value
Blood Pressure
Systolic (SBP) 90-140 mmHg
Diastolic (DBP) 60-90mmHg
Mean Arterial Pressure (MAP) 70 - 100 mm Hg
Cardiac Index (CI) CI=CO/BSA
2.5-4 L/min/m2
Cardiac Output (CO) 4-8 L/min
Central Venous Pressure (CVP) (also known as
Right Atrial Pressure (RA))
2-6 mmHg
Pulmonary Artery Pressure (PA)
Systolic 20-30 mmHg (PAS)
Diastolic 8-12 mmHg (PAD)
Mean 25 mmHg (PAM)
Pulmonary Capillary Wedge Pressure (PWCP) 4-12 mmHg
Pulmonary Vascular Resistance (PVR) 37-250 dynes/sec/cm5
Right Ventricular Pressure (RV)
Systolic-20-30 mmHg
Diastolic 0-5 mmHg
Stroke Index (SI) 25 - 45 ml/m2
Stroke Volume (SV) 50 - 100 ml
Normal
Variables
 The symptoms of obstructive shock are considered emergencies because
they can lead to organ failure, tissue death, and death.
 Symptoms that are associated with neurological function include confusion,
loss of consciousness, and inability to concentrate.
 The symptoms that are related to the heart and its function are chest pain,
lightheadedness, and a sudden increase in heart rate along with a faint pulse.
 Respiratory symptoms consist of shortness of breath and fast but shallow
breathing.
 Other symptoms include sweating, decreased urine output, clammy skin,
pallor, and cold hands and feet.
Symptoms of Obstructive Shock
 As with all forms of shock, the management of obstructive shock should center around
the fundamental components for the treatment of shock.
 The following should be considered:
◦ Positioning,
◦ Airway and breathing,
◦ Vascular access,
◦ Fluid resuscitation,
◦ Monitoring,
◦ Frequent reassessment,
◦ Lab studies,
◦ Medication therapy,
◦ Expert consultation.
Fundamentals of Shock Management:
 Occurs as a direct result of
myocardial dysfunction.
 Heart failure to pump
adequately
 Very rare to occur but often fatal.
 Diminished Cardiac Output,
 End organ hypoperfusion
 Hypoxia
Cardiogenic
Shock
 Low myocardial contractility
 MI
 Hypotension
 Systemic vasodilation
 Coronary artery disease
 The hallmark is peripheral
vasoconstriction and vital end‐organ
damage, which stems from ineffective
stroke volume and insufficient
circulatory compensation.
 This may, for a while, improve cardia
tissue perfusion but it increases the
afterload and workload on cardiac
muscle increases the damage.
Pathophysiol
ogy
 In the setting of CS, classic ACS symptoms and
signs are combined with
◦ altered mental status,
◦ hypotension,
◦ arrhythmia,
◦ diminished pulses,
◦ dyspnea,
◦ peripheral edema,
◦ These features reflect an infarction involving
>40% of the left ventricle
Clinical Presentations
 The four common clinical signs that
distinguish cardiogenic shock are
◦ Tachycardia,
◦ Dyspnea,
◦ Jugular vein distention,
◦ Hepatomegaly
 Increased respiratory effort is often
the distinguishing characteristic
that sets cardiogenic shock apart
from other forms of shock.
 Primary assessment model (ABCDE)
 Airway:
◦ typically no airway abnormalities
and patent airway
 Breathing:
◦ tachypena, and pulmonary
edema
 Circulation:
◦ tachycardia, weak or
absent peripheral pulses,
jugular venous
distention, low BP with a
narrow pulse pressure,
delayed capillary refill,
signs of congestive heart
failure, and oliguria
 Disability:
◦ anxiety, confusion,
restlessness, drowsiness,
and coma
 Exposure:
◦ pale, cool, and
diaphoresis
Signs of
Cardiogenic
Shock:
 ECG
 Chest X-ray
 BNP test.(BNP levels below 100 picograms per milliliter (pg/mL))
Investigation
Unlike other forms of shock which improve
with aggressive fluid resuscitation, rapid fluid
resuscitation with cardiogenic shock can be
counterproductive and may worsen the
patient’s condition.
Fluid overload and pulmonary edema may
occur.
Caution should be used when administering
fluids in the presence of cardiogenic shock.
Manageme
nt Of
Cardiogeni
c Shock
Improve cardiac function.
Improve cardiac output.
Improve tissue perfusion.
Decrease myocardial oxygen demand.
Any drug that causes an
increase in systemic vascular
resistance (SVR) (afterload)
should be avoided.
This includes phenylephrine and
norepinephrine which both cause
potent vasoconstriction
Goals of
Manageme
nt
 Improve Cardiac Function
◦ Reduce SVR
◦ Dobutamine, milrinone, dopamine, and epinephrine
◦ Nitroprusside, which is a pure vasodilator, it may be necessary to use dopamine or
epinephrine to improve perfusion pressure when nitroprusside is administered.
◦ Diuretics may also be used if there is evidence of pulmonary edema or systemic venous
congestion.
 Decreasing Oxygen Demand
◦ intubation and mechanical ventilation,
◦ maintenance of a normal temperature,
◦ and patient sedation.
 Identification of the etiology is of primary importance because the etiology will
direct the course of treatment. Early expert consultation should be obtained.
Management Of Cardiogenic Shock
 Inotropic agents. You might be given medications to improve your heart function, such as
norepinephrine (Levophed) or dopamine, until other treatments start to work.
 Aspirin. Emergency medical workers might give you aspirin immediately to reduce blood clotting
and keep your blood flowing through a narrowed artery. Take an aspirin yourself while waiting for
help to arrive only if your doctor has previously told you to do so for symptoms of a heart attack.
 Thrombolytics. These drugs, also called clot busters or fibrinolytics, help dissolve a blood clot that's
blocking blood flow to your heart. The sooner you receive a thrombolytic drug after a heart attack,
the greater your chances of survival. You'll likely receive thrombolytics, such as alteplase (Activase) or
reteplase (Retavase), only if emergency cardiac catheterization isn't available.
 Antiplatelet medication. Emergency room doctors might give you drugs similar to aspirin to help
prevent new clots from forming. These include medications, such as oral clopidogrel (Plavix), and
platelet glycoprotein IIb/IIIa receptor blockers, such as abciximab (Reopro), tirofiban (Aggrastat) and
eptifibatide (Integrilin), which are given through a vein (intravenously).
 Other blood-thinning medications. You'll likely be given other medications, such as heparin, to
make your blood less likely to form clots. IV or injectable heparin usually is given during the first few
days after a heart attack.
Treatment of Cardiogenic Shock
 Angioplasty and stenting. If a blockage is found during a cardiac
catheterization, your doctor can insert a long, thin tube (catheter)
equipped with a special balloon through an artery, usually in your leg,
to a blocked artery in your heart. Once in position, the balloon is
briefly inflated to open the blockage.
 A metal mesh stent might be inserted into the artery to keep it open
over time. In most cases, you doctor will place a stent coated with a
slow-releasing medication to help keep your artery open.
 Balloon pump. Your doctor inserts a balloon pump in the main artery
of your heart (aorta). The pump inflates and deflates within the aorta,
helping blood flow and taking some of the workload off your heart.
Medical Procedures
 Coronary artery bypass surgery. This involves sewing veins or arteries in place
at a site beyond a blocked coronary artery. Your doctor might suggest this
procedure after your heart has had time to recover from your heart attack.
Occasionally, bypass surgery is performed on an emergency basis.
 Surgery to repair an injury to your heart. Sometimes an injury, such as a tear
in one of your heart's chambers or a damaged heart valve, can cause
cardiogenic shock. Surgery might correct the problem.
 Ventricular assist device. A mechanical device can be implanted into the
abdomen and attached to the heart to help it pump. This might extend and
improve the lives of some people with end-stage heart failure who are waiting
for new hearts or aren't able to have heart transplantation.
 Heart transplant. If your heart is so damaged that no other treatments work, a
heart transplant may be a last resort
Surgical Procedure
 reduction in intravascular fluid volume.
◦ causes a decrease in stroke volume because of the resulting decrease in
preload
◦ Decreases cardiac output.
 Causes
◦ Dehydration from vomiting and diarrhea,
◦ Hemorrhage,
◦ Decreased intake of fluids,
◦ Pathologic urinary losses (e.g. diabetic ketoacidosis, diabetes insipidus),
◦ Translocation of body fluids (e.g. burns, peritonitis, small bowel
obstruction).
Hypovolemic Shock
 Increased HR,
 Increased afterload,
 and/or Increased contractility.
 Those are altered in compensation to hypovolemia, a viable
effort to maintain CO.
 But alteration is the key to diagnose hypovolemic shock.
Compensatory Mechanisms In Hypovolemia
 The Primary Assessment acronym stands for Airway, Breathing, Circulation,
Disability, and Exposure.
 A: Typically the airway of the child with hypovolemic shock will not be significantly
affected.
 B: The patient may experience some Breathing changes and this may be
recognized by a nonlabored tachypnea. (With no effort)
 C: The most notable changes will likely be seen with circulation. These circulation
changes include tachycardia, narrowing pulse pressure, possible systolic
hypotension, capillary refill time > 2 seconds, cool/pale skin, weak to absent
peripheral pulses, reduced urine output.
 D: Disability or neurological changes include decreased level of consciousness.
 E: Exposing the patient to observe the skin and extremities will often reveal cool,
pale, and mottled extremities
Sign and Symptoms (ABCDE Acronyms)
• compensatory mechanisms can maintain systolic
blood pressure. This window of time is classified
as compensated shock.
If compensatory mechanisms fail and hypotensive
shock (low systolic BP) develops, the chances of
survival and recovery are significantly decreased
◦ For 0 - 10 kg = weight (kg) x 100 mL/kg/day.
◦ For 10-20 kg = 1000 mL + [weight (kg) x 50 ml/kg/day]
◦ For > 20 kg = 1500 mL + [weight (kg) x 20 ml/kg/day]
 [Na+] in serum = TBS ÷ TBW ……………………………….equation 1
That means
 TBS = [Na+] in serum x TBW ……………………………… equation 2
 [Na+]high TBW1 = [Na+]desired (TBW1 + X)
∗ ∗
Where X is the free water deficit. If the desired sodium is 140, rearranging the equation and
solving for X gives you:
 X = {([Na+]high – 140) ÷ 140 } TBW1
∗
 TBW = Wt (kg) x 0.6 for males
TBW = Wt (kg) x 0.5 for females.
 If elderly, use 0.5 for males and 0.45 for females.
 To maintain their serum sodium concentrations at 140 mEq/L (140 mmol/L), infants also must
retain approximately 360 mEq (360 mmol) of sodium or 2 mEq/d (2 mmol/d).
Calculating fluid for Maintenance
 Excessive vasodilation and impaired distribution of blood flow.
 Anaphylactic and septic shock
 Neurogenic shock
Distributive Shock
 Hyperdynamic state development.
 Inadequate tissue perfusion
 Intraorgan shunting
 Hypotensive state with increase mixed venous oxygen saturation.
 Early Septic Shock (warm or hyperdynamic)
◦ Reduced diastolic Blood Pressure
◦ Flushed warm extremities
◦ Brisk capillary refill from peripheral vasodilation and increased cardiac output.
 Late Septic Shock (cold or Hypodynamic)
◦ Decreased myocardial Contractility
◦ Paralyzed microvascular tone
◦ Pressure dependent reduction in organ perfusion (Hypoperfusion)
Pathophysiology
 Anaphylactic
◦ Decreased SVR; histamine release from mast cells after activation of
antigen bound immunoglobulin (IgE)
◦ Increased prostaglandins
 Neurogenic Shock
◦ Loss of sympathetic tone due to severe injury to the nervous system.
Pathophysiology (anaphylactic/ neurogenic)
 Anaphylaxis
◦ Respiratory distress
◦ Wheezing
◦ Urticarial rashes
◦ Angioedema
◦ High grade fever in septic shock
Clinical Signs
 CBC
 Urinalysis
 Electrolytes
 Blood urea Nitrogen (BUN)
 Creatinine
 Glucose
 Urine cultures
 Blood cultures
 Possible ABGs or VBGs
 Serum lactate
 Total Circulating blood Volume (TCBV)
 Microcirculatory Imaging
 Thoracic bioelectrical Impedance (TBI)
 In case of pneumonia
◦ Sputum gram stain and cultures
 Intra-abdominal pathology or hepatic
insufficiency
◦ Serum bilirubin
◦ ALP, ALT, AST
◦ PT/aPTT, INR
◦ Amylase, lipase
 DIC suspicion
◦ PT/aPTT, fibrin split products, fibrinogen
levels, platelets level.
 ECG,CT scan, X-ray etc.
 TEE/TTE
 Arterial Catheters, Venous Catheters
Work up
DDx PCWP (pulmonary capillary
wedge pressure)
Cardiac Output
Cardiogenic Shock increased Decreased (due to mechanical
defect)
Extra Cardiac obstructive
Shock
1. Pericardial tamponade
2. Pulmonary embolism
Increased
Normal or decreased
Decreased
Decreased
Hypovolemic Shock Decreased Decreased
Distributive Shock
1. Septic Shock
2. Anaphylactic Shock
Normal or decreased
Normal or decreased
Increased or normal
Increased or normal

Lecture different types of Shock and Its Management.pptx

  • 1.
    Shock and Its Management prepby shah Fahad Khalid BS Cardiology KMU/IPMS(GM) Lecturer at Abasyn university
  • 2.
    Introduction to shock Possiblecauses of shock Pre-shock symptoms Sign and symptoms Assessment of Shock Patient Generalized Treatment Types of shock Management of each shock type accordingly Monitoring and care to the shock patient Topic Outlines
  • 3.
     Acute circulatoryfailure.  Decreased organs perfusion.  Inadequate oxygen delivery.  End organ dysfunction.  Actually it is the imbalance between demand and supply of oxygen.  Inability to utilize oxygen  A temporary stage of unconsciousness. Shock
  • 4.
     Failure ofoxygen delivery system ◦ Hypoxia ◦ Oxygen deficient environment i.e. high altitude.  Injury to the lungs/ Lung disease/ unable to transform oxygen into the blood. ◦ Pneumonia ◦ CHF ◦ Traumatized lungs ◦ Pulmonary embolism ◦ Pulmonary edema ◦ Hemo/hydro/pneumothorax ◦ Respiratory arrest  Burns  Diarrhea/vomiting (persistent)  Spinal injuries (neurogenic)  Heart related problems ◦ CHF ◦ MI ◦ Heart attack/cardiac arrest ◦ Arrhythmias ◦ Pericarditis/endocarditis ◦ Pericardial effusion ◦ CAD  RBCs related ◦ Anemia ◦ Bleeding disorders ◦ Hemolysis  Body fluids (dehydration)  Hypotension due to vasodilation or any other causes. Possible Causes of Shock
  • 5.
     Rapid butshallow breathing  Feeling to get fainted  Dizziness starts  Blacking out of eye  Nausea  Feeling of General weakness  Facial flushing Pre-shock Symptoms
  • 6.
     Low Bp Tachycardia (compensatory)  Rapid but shallow breathing persists  Cold and clammy skin  Rapid but weak pulse  Dizziness/fainting  General weakness  Type dependent sign and symptoms ◦ Anxiety or agitation ◦ Seizures ◦ Confusion/ unresponsiveness ◦ Low or no urine output ◦ Peripheral cyanosis ◦ Sweating ◦ Chest pain. Sign and Symptoms
  • 7.
     ABC Protocol ◦Airway ◦ Breathing ◦ Circulation  ABCDE Protocols ◦ Airway ◦ Breathing ◦ Circulation ◦ Disability ◦ Exposure  BLUE protocol: Bed Side Lung Ultrasonography in Emergency.  FALLS Protocol: Fluid Administration Limited by Lungs Sonography.  GCS scaling(15) Assessment Protocols
  • 8.
  • 9.
     Main types ◦Obstructive Shock ◦ Cardiogenic Shock ◦ Distributive Shock ◦ Hypovolemic Shock Types of Shock
  • 10.
     Actual physicalcause  Underlying pathology  Optimization of ◦ Cardiac output ◦ Blood pressure ◦ Oxygen delivery  Vascular tone restoration  Prevent any end organ failure  Or at least give supportive therapy (pharmacological/prophylactic). Generalized Treatment
  • 11.
     Obstruction ofblood flow into / out of the heart.  Impaired diastolic filling and decreased cardiac output.  Causes: ◦ Pulmonary ◦ Circulatory occlusion ◦ Heart itself  Acute pericardial tamponade,  Pulmonary or systemic hypertension  Massive pulmonary emboli occluding >50% of vascular bed. Obstructiv e Shock
  • 12.
     CO isdecreased  CVP is elevated,  SVR is increased, and  Echocardiography is the definitive diagnostic tool for Obstructive shock. Diagnostic Variables
  • 13.
    Parameter Normal value BloodPressure Systolic (SBP) 90-140 mmHg Diastolic (DBP) 60-90mmHg Mean Arterial Pressure (MAP) 70 - 100 mm Hg Cardiac Index (CI) CI=CO/BSA 2.5-4 L/min/m2 Cardiac Output (CO) 4-8 L/min Central Venous Pressure (CVP) (also known as Right Atrial Pressure (RA)) 2-6 mmHg Pulmonary Artery Pressure (PA) Systolic 20-30 mmHg (PAS) Diastolic 8-12 mmHg (PAD) Mean 25 mmHg (PAM) Pulmonary Capillary Wedge Pressure (PWCP) 4-12 mmHg Pulmonary Vascular Resistance (PVR) 37-250 dynes/sec/cm5 Right Ventricular Pressure (RV) Systolic-20-30 mmHg Diastolic 0-5 mmHg Stroke Index (SI) 25 - 45 ml/m2 Stroke Volume (SV) 50 - 100 ml Normal Variables
  • 14.
     The symptomsof obstructive shock are considered emergencies because they can lead to organ failure, tissue death, and death.  Symptoms that are associated with neurological function include confusion, loss of consciousness, and inability to concentrate.  The symptoms that are related to the heart and its function are chest pain, lightheadedness, and a sudden increase in heart rate along with a faint pulse.  Respiratory symptoms consist of shortness of breath and fast but shallow breathing.  Other symptoms include sweating, decreased urine output, clammy skin, pallor, and cold hands and feet. Symptoms of Obstructive Shock
  • 15.
     As withall forms of shock, the management of obstructive shock should center around the fundamental components for the treatment of shock.  The following should be considered: ◦ Positioning, ◦ Airway and breathing, ◦ Vascular access, ◦ Fluid resuscitation, ◦ Monitoring, ◦ Frequent reassessment, ◦ Lab studies, ◦ Medication therapy, ◦ Expert consultation. Fundamentals of Shock Management:
  • 16.
     Occurs asa direct result of myocardial dysfunction.  Heart failure to pump adequately  Very rare to occur but often fatal.  Diminished Cardiac Output,  End organ hypoperfusion  Hypoxia Cardiogenic Shock
  • 17.
     Low myocardialcontractility  MI  Hypotension  Systemic vasodilation  Coronary artery disease  The hallmark is peripheral vasoconstriction and vital end‐organ damage, which stems from ineffective stroke volume and insufficient circulatory compensation.  This may, for a while, improve cardia tissue perfusion but it increases the afterload and workload on cardiac muscle increases the damage. Pathophysiol ogy
  • 18.
     In thesetting of CS, classic ACS symptoms and signs are combined with ◦ altered mental status, ◦ hypotension, ◦ arrhythmia, ◦ diminished pulses, ◦ dyspnea, ◦ peripheral edema, ◦ These features reflect an infarction involving >40% of the left ventricle Clinical Presentations
  • 19.
     The fourcommon clinical signs that distinguish cardiogenic shock are ◦ Tachycardia, ◦ Dyspnea, ◦ Jugular vein distention, ◦ Hepatomegaly  Increased respiratory effort is often the distinguishing characteristic that sets cardiogenic shock apart from other forms of shock.  Primary assessment model (ABCDE)  Airway: ◦ typically no airway abnormalities and patent airway  Breathing: ◦ tachypena, and pulmonary edema  Circulation: ◦ tachycardia, weak or absent peripheral pulses, jugular venous distention, low BP with a narrow pulse pressure, delayed capillary refill, signs of congestive heart failure, and oliguria  Disability: ◦ anxiety, confusion, restlessness, drowsiness, and coma  Exposure: ◦ pale, cool, and diaphoresis Signs of Cardiogenic Shock:
  • 20.
     ECG  ChestX-ray  BNP test.(BNP levels below 100 picograms per milliliter (pg/mL)) Investigation
  • 21.
    Unlike other formsof shock which improve with aggressive fluid resuscitation, rapid fluid resuscitation with cardiogenic shock can be counterproductive and may worsen the patient’s condition. Fluid overload and pulmonary edema may occur. Caution should be used when administering fluids in the presence of cardiogenic shock. Manageme nt Of Cardiogeni c Shock
  • 22.
    Improve cardiac function. Improvecardiac output. Improve tissue perfusion. Decrease myocardial oxygen demand. Any drug that causes an increase in systemic vascular resistance (SVR) (afterload) should be avoided. This includes phenylephrine and norepinephrine which both cause potent vasoconstriction Goals of Manageme nt
  • 23.
     Improve CardiacFunction ◦ Reduce SVR ◦ Dobutamine, milrinone, dopamine, and epinephrine ◦ Nitroprusside, which is a pure vasodilator, it may be necessary to use dopamine or epinephrine to improve perfusion pressure when nitroprusside is administered. ◦ Diuretics may also be used if there is evidence of pulmonary edema or systemic venous congestion.  Decreasing Oxygen Demand ◦ intubation and mechanical ventilation, ◦ maintenance of a normal temperature, ◦ and patient sedation.  Identification of the etiology is of primary importance because the etiology will direct the course of treatment. Early expert consultation should be obtained. Management Of Cardiogenic Shock
  • 24.
     Inotropic agents.You might be given medications to improve your heart function, such as norepinephrine (Levophed) or dopamine, until other treatments start to work.  Aspirin. Emergency medical workers might give you aspirin immediately to reduce blood clotting and keep your blood flowing through a narrowed artery. Take an aspirin yourself while waiting for help to arrive only if your doctor has previously told you to do so for symptoms of a heart attack.  Thrombolytics. These drugs, also called clot busters or fibrinolytics, help dissolve a blood clot that's blocking blood flow to your heart. The sooner you receive a thrombolytic drug after a heart attack, the greater your chances of survival. You'll likely receive thrombolytics, such as alteplase (Activase) or reteplase (Retavase), only if emergency cardiac catheterization isn't available.  Antiplatelet medication. Emergency room doctors might give you drugs similar to aspirin to help prevent new clots from forming. These include medications, such as oral clopidogrel (Plavix), and platelet glycoprotein IIb/IIIa receptor blockers, such as abciximab (Reopro), tirofiban (Aggrastat) and eptifibatide (Integrilin), which are given through a vein (intravenously).  Other blood-thinning medications. You'll likely be given other medications, such as heparin, to make your blood less likely to form clots. IV or injectable heparin usually is given during the first few days after a heart attack. Treatment of Cardiogenic Shock
  • 25.
     Angioplasty andstenting. If a blockage is found during a cardiac catheterization, your doctor can insert a long, thin tube (catheter) equipped with a special balloon through an artery, usually in your leg, to a blocked artery in your heart. Once in position, the balloon is briefly inflated to open the blockage.  A metal mesh stent might be inserted into the artery to keep it open over time. In most cases, you doctor will place a stent coated with a slow-releasing medication to help keep your artery open.  Balloon pump. Your doctor inserts a balloon pump in the main artery of your heart (aorta). The pump inflates and deflates within the aorta, helping blood flow and taking some of the workload off your heart. Medical Procedures
  • 26.
     Coronary arterybypass surgery. This involves sewing veins or arteries in place at a site beyond a blocked coronary artery. Your doctor might suggest this procedure after your heart has had time to recover from your heart attack. Occasionally, bypass surgery is performed on an emergency basis.  Surgery to repair an injury to your heart. Sometimes an injury, such as a tear in one of your heart's chambers or a damaged heart valve, can cause cardiogenic shock. Surgery might correct the problem.  Ventricular assist device. A mechanical device can be implanted into the abdomen and attached to the heart to help it pump. This might extend and improve the lives of some people with end-stage heart failure who are waiting for new hearts or aren't able to have heart transplantation.  Heart transplant. If your heart is so damaged that no other treatments work, a heart transplant may be a last resort Surgical Procedure
  • 27.
     reduction inintravascular fluid volume. ◦ causes a decrease in stroke volume because of the resulting decrease in preload ◦ Decreases cardiac output.  Causes ◦ Dehydration from vomiting and diarrhea, ◦ Hemorrhage, ◦ Decreased intake of fluids, ◦ Pathologic urinary losses (e.g. diabetic ketoacidosis, diabetes insipidus), ◦ Translocation of body fluids (e.g. burns, peritonitis, small bowel obstruction). Hypovolemic Shock
  • 28.
     Increased HR, Increased afterload,  and/or Increased contractility.  Those are altered in compensation to hypovolemia, a viable effort to maintain CO.  But alteration is the key to diagnose hypovolemic shock. Compensatory Mechanisms In Hypovolemia
  • 29.
     The PrimaryAssessment acronym stands for Airway, Breathing, Circulation, Disability, and Exposure.  A: Typically the airway of the child with hypovolemic shock will not be significantly affected.  B: The patient may experience some Breathing changes and this may be recognized by a nonlabored tachypnea. (With no effort)  C: The most notable changes will likely be seen with circulation. These circulation changes include tachycardia, narrowing pulse pressure, possible systolic hypotension, capillary refill time > 2 seconds, cool/pale skin, weak to absent peripheral pulses, reduced urine output.  D: Disability or neurological changes include decreased level of consciousness.  E: Exposing the patient to observe the skin and extremities will often reveal cool, pale, and mottled extremities Sign and Symptoms (ABCDE Acronyms)
  • 31.
    • compensatory mechanismscan maintain systolic blood pressure. This window of time is classified as compensated shock. If compensatory mechanisms fail and hypotensive shock (low systolic BP) develops, the chances of survival and recovery are significantly decreased
  • 32.
    ◦ For 0- 10 kg = weight (kg) x 100 mL/kg/day. ◦ For 10-20 kg = 1000 mL + [weight (kg) x 50 ml/kg/day] ◦ For > 20 kg = 1500 mL + [weight (kg) x 20 ml/kg/day]  [Na+] in serum = TBS ÷ TBW ……………………………….equation 1 That means  TBS = [Na+] in serum x TBW ……………………………… equation 2  [Na+]high TBW1 = [Na+]desired (TBW1 + X) ∗ ∗ Where X is the free water deficit. If the desired sodium is 140, rearranging the equation and solving for X gives you:  X = {([Na+]high – 140) ÷ 140 } TBW1 ∗  TBW = Wt (kg) x 0.6 for males TBW = Wt (kg) x 0.5 for females.  If elderly, use 0.5 for males and 0.45 for females.  To maintain their serum sodium concentrations at 140 mEq/L (140 mmol/L), infants also must retain approximately 360 mEq (360 mmol) of sodium or 2 mEq/d (2 mmol/d). Calculating fluid for Maintenance
  • 33.
     Excessive vasodilationand impaired distribution of blood flow.  Anaphylactic and septic shock  Neurogenic shock Distributive Shock
  • 34.
     Hyperdynamic statedevelopment.  Inadequate tissue perfusion  Intraorgan shunting  Hypotensive state with increase mixed venous oxygen saturation.  Early Septic Shock (warm or hyperdynamic) ◦ Reduced diastolic Blood Pressure ◦ Flushed warm extremities ◦ Brisk capillary refill from peripheral vasodilation and increased cardiac output.  Late Septic Shock (cold or Hypodynamic) ◦ Decreased myocardial Contractility ◦ Paralyzed microvascular tone ◦ Pressure dependent reduction in organ perfusion (Hypoperfusion) Pathophysiology
  • 35.
     Anaphylactic ◦ DecreasedSVR; histamine release from mast cells after activation of antigen bound immunoglobulin (IgE) ◦ Increased prostaglandins  Neurogenic Shock ◦ Loss of sympathetic tone due to severe injury to the nervous system. Pathophysiology (anaphylactic/ neurogenic)
  • 36.
     Anaphylaxis ◦ Respiratorydistress ◦ Wheezing ◦ Urticarial rashes ◦ Angioedema ◦ High grade fever in septic shock Clinical Signs
  • 37.
     CBC  Urinalysis Electrolytes  Blood urea Nitrogen (BUN)  Creatinine  Glucose  Urine cultures  Blood cultures  Possible ABGs or VBGs  Serum lactate  Total Circulating blood Volume (TCBV)  Microcirculatory Imaging  Thoracic bioelectrical Impedance (TBI)  In case of pneumonia ◦ Sputum gram stain and cultures  Intra-abdominal pathology or hepatic insufficiency ◦ Serum bilirubin ◦ ALP, ALT, AST ◦ PT/aPTT, INR ◦ Amylase, lipase  DIC suspicion ◦ PT/aPTT, fibrin split products, fibrinogen levels, platelets level.  ECG,CT scan, X-ray etc.  TEE/TTE  Arterial Catheters, Venous Catheters Work up
  • 38.
    DDx PCWP (pulmonarycapillary wedge pressure) Cardiac Output Cardiogenic Shock increased Decreased (due to mechanical defect) Extra Cardiac obstructive Shock 1. Pericardial tamponade 2. Pulmonary embolism Increased Normal or decreased Decreased Decreased Hypovolemic Shock Decreased Decreased Distributive Shock 1. Septic Shock 2. Anaphylactic Shock Normal or decreased Normal or decreased Increased or normal Increased or normal

Editor's Notes

  • #3 Septic shock - This is caused by an overwhelming infection leading to vasodilation, such as by Gram negative bacteria i.e. Escherichia coli, Proteus species, Klebsiella pneumoniae which release an endotoxin which produces adverse biochemical, immunological and occasionally neurological effects which are harmful to the body. Gram-positive cocci, such as pneumococci and streptococci, and certain fungi as well as Gram-positive bacterial toxins produce a similar syndrome. Anaphylactic shock - Caused by a severe anaphylactic reaction to an allergen, antigen, drug or foreign protein causing the release of histamine which causes widespread vasodilation, leading to hypotension and increased capillary permeability. Neurogenic shock - Neurogenic shock is the rarest form of shock. It is caused by trauma to the spinal cord resulting in the sudden loss of autonomic and motor reflexes below the injury level. Without stimulation by sympathetic nervous system the vessel walls relax uncontrolled, resulting in a sudden decrease in peripheral vascular resistance, leading to vasodilation and hypotension.